Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma

Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinations

1985 • 324 citations

PERSISTENT B19 PARVOVIRUS INFECTION AS A CAUSE OF SEVERE CHRONIC ANAEMIA IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKAEMIA

1988 • 300 citations

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

1988 • 162 citations

STERILISATION OF HEPATITIS AND HTLV-III VIRUSES BY EXPOSURE TO TRI(n-BUTYL)PHOSPHATE AND SODIUM CHOLATE

1986 • 142 citations

Antituberculous Effect of Certain Surface-Active Polyoxyethylene Ethers in Mice

1951 • 107 citations

VIRUCIDAL TREATMENT OF CLOTTING FACTOR CONCENTRATES

1988 • 82 citations

Blood donor screening for parvovirus B19

1990 • 81 citations

Tri(n‐Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic and Experimental Blood Derivatives¹

1987 • 66 citations

The use of tri(n‐butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation

1990 • 64 citations

The development of virus-free labile blood derivatives ? A review

1987 • 57 citations

Procedures for the inactivation of viruses in clotting factor concentrates

1986 • 53 citations

Tolerance of Intravenously Administered Lipid in Newborns

1985 • 19 citations

Quantitative Assays for Evaluation of HTLV-III Inactivation Procedures: Tri(N-butyl)phosphate:sodium cholate and β-Propiolactone

1985 • 17 citations

Inactivation of Viruses Found with Plasma Proteins

1991 • 14 citations

Measures to inactivate viral contaminants of pooled plasma products.

1985 • 13 citations

[Virus inactivation in plasma fractions for therapeutic use].

1987 • 9 citations